Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Other solid neoplasm 1Dermatologic 1

Conditions

Glioblastoma 3Brain Neoplasms 3Recurrence 2Neoplasm Metastasis 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × verubulin × CNS × Clear all
NCT01285414 2012-04-11

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Myrexis Inc.

Phase 2 Completed
5 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT00892931 2011-10-14

Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme

Myrexis Inc.

Phase 2 Completed
56 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

NCT00635557 2011-03-25

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Myrexis Inc.

Phase 1/2 Unknown
30 enrolled
CNS

Glioblastoma, Recurrence

NCT00393965 2008-02-13

Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases

Myrexis Inc.

Phase 1 Completed
18 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡